Showing results (101-110 of 120) with videos related to

Sort By:
Pageof 12
Gut|May 4, 2015
Reliability among central readers in the evaluation of endoscopic findings from patients with Crohn's diseaseReena Khanna, Guangyong Zou, Geert D'Haens, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 31, 2013
Herd protection by a bivalent killed whole-cell oral cholera vaccine in the slums of Kolkata, IndiaMohammad Ali, Dipika Sur, Young Ae You, et al.
Bulletin of the World Health Organization|February 26, 2008
Methodological considerations in implementing the WHO Global Survey for Monitoring Maternal and Perinatal HealthArchana Shah, Anibal Faundes, M'Imunya Machoki, et al.
BMJ (Clinical Research Ed.)|November 6, 2007
Maternal and neonatal individual risks and benefits associated with caesarean delivery: multicentre prospective studyJosé Villar, Guillermo Carroli, Nelly Zavaleta, et al.
Lancet (London, England)|June 7, 2006
Caesarean delivery rates and pregnancy outcomes: the 2005 WHO global survey on maternal and perinatal health in Latin AmericaJosé Villar, Eliette Valladares, Daniel Wojdyla, et al.
The New England Journal of Medicine|July 24, 2009
A cluster-randomized effectiveness trial of Vi typhoid vaccine in IndiaDipika Sur, R Leon Ochiai, Sujit K Bhattacharya, et al.
Lancet (London, England)|September 7, 2015
Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trialReena Khanna, Brian Bressler, Barrett G Levesque, et al.
Paediatric and Perinatal Epidemiology|February 27, 2008
Intracluster correlation coefficients from the 2005 WHO Global Survey on Maternal and Perinatal Health: implications for implementation researchMonica Taljaard, Allan Donner, José Villar, et al.
Lancet (London, England)|October 13, 2009
Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trialDipika Sur, Anna Lena Lopez, Suman Kanungo, et al.
Gastroenterology|November 26, 2013
Methotrexate in combination with infliximab is no more effective than infliximab alone in patients with Crohn's diseaseBrian G Feagan, John W D McDonald, Remo Panaccione, et al.
Pageof 12